Corneal cross-linking is now available at the Bay Area Eye Institute
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, recently received FDA approval for corneal cross-linking, a medical procedure that combines the use of ultra-violet (UV) light and riboflavin (vitamin B2) eye drops.
Dr. Craig Berger is excited to announce the recent approval of this minimally invasive treatment, corneal collagen cross-linking for keratoconus! Corneal collagen cross-linking is NOW AVAILABLE at the Bay Area Eye Institute in Tampa, Florida.
Corneal Collagen Cross-Linking:
- Creates new corneal collagen cross-links
- Results in a shortening and thickening of the collagen fibrils
- Leads to the stiffening of the cornea
Corneal cross-linking provides patients a much-needed option to treat this debilitating disease. Patients suffering from progressive keratoconus can now receive a therapeutic treatment that has been rigorously tested and approved.
Doctor Berger is now offering corneal collagen cross-linking , the only FDA-approved therapeutic treatment for progressive keratoconus, to his Tampa Bay area keratoconus patients. Book an appointment with Dr. Berger to find out if corneal cross-linking is right for you.